help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valove, F. M.
Right arrow Articles by Flack, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valove, F. M.
Right arrow Articles by Flack, M. R.

Endocrinology, Vol 135, 2657-2661, Copyright © 1994 by Endocrine Society


ARTICLES

Receptor binding and signal transduction are dissociable functions requiring different sites on follicle-stimulating hormone

FM Valove, C Finch, JN Anasti, J Froehlich and MR Flack
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Separate sites for glycoprotein hormone receptor binding and signal transduction have yet to be elucidated. In general, certain peptide regions are thought to be critical for receptor binding, whereas the oligosacharides are thought to be important for signal transduction. Using site-directed mutagenesis of FSH, we made selective amino acid substitutions and oligosaccharide alterations to try and identify specific sites mediating receptor binding distinct from signal transduction and vice versa. We substituted Lys or Asp for beta Arg35 in the purported receptor binding loop between cysteine-32 and -51, and we substituted Gln for alpha Asn52, alpha Asn78, beta Asn7, or beta Asn24, the attachment sites for each of the oligosaccharide side- chains. We determined the binding and signal-transducing activity of wild-type and mutant human FSH at the human FSH receptor, as recent data suggest that glycoprotein hormone-receptor interactions are species specific. The binding activities of FSH with Lys or Asp substituted for beta Arg35 were reduced 71% and 98%, respectively, but their signal transduction, at equivalent levels of binding activity, was unaffected. The binding activity of FSH lacking the oligosaccharide at alpha Asn52 was enhanced 2- to 3-fold, but its signal-transducing activity, at equivalent levels of receptor binding, was decreased 72%. In contrast, the binding and signal-transducing activities of FSH lacking the alpha Asn78, or alpha Asn7, or beta Asn24 oligosaccharide were unaffected. Thus, a specific amino acid (beta Arg35) is important for high affinity binding, but is not involved in signal transduction, whereas a specific oligosaccharide (alpha Asn52) is important for signal transduction, but is not required for high affinity binding. Therefore, receptor binding and signal transduction are dissociable functions involving different sites on the FSH glycoprotein.


This article has been cited by other articles:


Home page
FASEB J.Home page
C.-H. Wong, D. D. Mruk, W. M. Lee, and C. Y. Cheng
Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate
FASEB J, February 1, 2007; 21(2): 438 - 448.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A. Leanos-Miranda, A. Ulloa-Aguirre, L. A Cervini, J. A. Janovick, J. Rivier, and P M. Conn
Identification of new gonadotrophin-releasing hormone partial agonists.
J. Endocrinol., June 1, 2006; 189(3): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kleinau, H. Jaschke, S. Neumann, J. Lattig, R. Paschke, and G. Krause
Identification of a Novel Epitope in the Thyroid-stimulating Hormone Receptor Ectodomain Acting as Intramolecular Signaling Interface
J. Biol. Chem., December 3, 2004; 279(49): 51590 - 51600.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Sudo, M. Kudo, S.-i. Wada, O. Sato, A. J.W. Hsueh, and S. Fujimoto
Genetic and functional analyses of polymorphisms in the human FSH receptor gene
Mol. Hum. Reprod., October 1, 2002; 8(10): 893 - 899.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. P. Rose, R. E. Gaines Das, and A. H. Balen
Definition and Measurement of Follicle Stimulating Hormone
Endocr. Rev., February 1, 2000; 21(1): 5 - 22.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
M. Simoni, J. Gromoll, and E. Nieschlag
The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology
Endocr. Rev., December 1, 1997; 18(6): 739 - 773.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. M. Fernandez and D. Puett
Lys[IMAGE] in the Third Extracellular Loop of the Lutropin/Choriogonadotropin Receptor Is Critical for Signaling
J. Biol. Chem., January 12, 1996; 271(2): 925 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. F. Kolakowski , Jr., B. Lu, C. Gerard, and N. P. Gerard
Probing the ``Message:Address'' Sites for Chemoattractant Binding to the C5a Receptor
J. Biol. Chem., July 28, 1995; 270(30): 18077 - 18082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society